Tricida inc.

Major-Pharmaceuticals

TCDA


7000 Shoreline Court
South San Francisco , CA 94080

Executive/
Director

Links

Price

  • Last Close
  • $ 0.11
    $ -0.01 -10 %
    Jan 23, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 31,125,310
  • Market Cap Full
  • $ 6.4M
  • Shares Outstanding
  • 58M
    Nov 9, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - 63.8% -5% -28.3% -14% -29.4% -
Q2 - - - 15% 12.1% 4% -17.4% 17.8% - -
Q3 - - - 1.8% -22.1% 8% 7.4% 8.3% - -
Q4 - - - -21.7% 22.2% -19.5% 106% -98.5% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 -29.4% - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%59%-81%31%-98%-29%0%

Earnings

2015 2016 2017 2018 2019 2020 2021
Q1 - - - -9 -0.9 -1.49 -1.06
Q2 - - - -10.89 -0.75 -1.16 -0.67
Q3 - - - -0.71 -0.89 -1.55 -0.79
Q4 - - - - -1.18 -1.09 -
A 0 0 0 -20.6 -3.7 -5.3 -3.4

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - 42.4 49.9 50.2 55.4
Jun - 49.1 50 50.3 55.4
Sep 42.1 49.4 50 50.4 55.7
Dec 42.1 49.6 50.2 50.4 58

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio 0.6 0.2 0.2 - -
Debt – Equity Ratio 1.8 0.2 0.2 - -
Interest Coverage -18.8 88.9 131.6 8.1 -18.5
Equity multiplier 0.4 0.2 - - -